ipamorelin empower – Research Peptide 4 Molecular Formula C38H49N9O5 Molecular Weight (g/mol) 711.85 Amino Acid Count 5 Amino Acid Sequence H IPAMORELIN PEPTIDE 2MG/5MG/10MG VIAL –

Delgobo, M

It is not FDA-approved for any medical use

Research on this peptide stems from the observation that the first 29 amino acids of GHRH are responsible for its main biological function

Typical daily range: 100250 mcg once daily (gradual titration recommended)

Key Features Dual-mechanism design: GHRH-receptor agonism (CJC-1295) + GHSR agonism (Ipamorelin) for complementary GH-axis interrogation 99% Purity (HPLC/MS verified): Consistent material for reproducible protocols Protocol-friendly kinetics: Short, high-amplitude GH pulse (Ipamorelin) alongside prolonged GH/IGF-1 support (CJC-1295) in model systems GMP-compliant manufacturing (USA): Batch-to-batch reliability COA included: Full lot documentation Specifications Identity: CJC-1295 /Ipamorelin USA cGMP Produced Form & Sizes: 10 mg vials Appearance: White to off-white lyophilized powder Purity: 99% (HPLC/MS verified) Manufacturing: GMP-compliant facility, USA Storage: 20 C, desiccated

Diabetes risk is potentially increased